Literature DB >> 21992559

Structural parameters governing activity of Pluronic triblock copolymers in hyperthermia cancer therapy.

Tianyi M Krupka1, Agata A Exner.   

Abstract

PURPOSE: To identify specific Pluronic triblock copolymer structural properties which are critical to its function as a sensitiser in hyperthermia treatment of experimental colorectal adenocarcinoma.
MATERIALS AND METHODS: DHD/K12/TRb rat colorectal adenocarcinoma cells were exposed to Pluronics, a family of triblock copolymers with the general structure EO(x)-PO(y)-EO(x) (EO: ethylene oxide, and PO: propylene oxide), at a range of molecular weights (Mw) and EO:PO:EO sub-unit lengths and then submitted to sublethal heat (43°C) treatment. Outcomes indicating Pluronic performance as a thermal sensitiser were correlated with its structural properties; lead candidates were determined accordingly. Finally, one of the lead candidates, Pluronic L61, a 2000 Da copolymer, was used to assess sensitising functionality in vivo in a subcutaneous rat model of colorectal carcinoma.
RESULTS: Pluronics with 1100 ≤ Mw ≤ 3200 Da and hydrophilic lipophilic balance (HLB) between 1-8 demonstrated the highest thermosensitising ability. Pluronics L31, L61, L62, L10 and L64 were found to be among the most effective copolymers for hyperthermia sensitisation under tested conditions. Most encouraging, L61 in synergy with hyperthermia significantly reduced tumour growth progression in vivo compared to tumours treated with hyperthermia alone.
CONCLUSIONS: Pluronic copolymer structure properties including, Mw, HLB and PO length are essential to its hyperthermia sensitising function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21992559      PMCID: PMC3293192          DOI: 10.3109/02656736.2011.599828

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  35 in total

1.  Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells.

Authors:  Elena V Batrakova; Shu Li; Valery Yu Alakhov; Donald W Miller; Alexander V Kabanov
Journal:  J Pharmacol Exp Ther       Date:  2003-02       Impact factor: 4.030

Review 2.  Pluronic block copolymers for overcoming drug resistance in cancer.

Authors:  Alexander V Kabanov; Elena V Batrakova; Valery Yu Alakhov
Journal:  Adv Drug Deliv Rev       Date:  2002-09-13       Impact factor: 15.470

Review 3.  An essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers.

Authors:  Alexander V Kabanov; Elena V Batrakova; Valery Yu Alakhov
Journal:  J Control Release       Date:  2003-08-28       Impact factor: 9.776

4.  Ultrasonically activated chemotherapeutic drug delivery in a rat model.

Authors:  Jared L Nelson; Beverly L Roeder; John C Carmen; Friederike Roloff; William G Pitt
Journal:  Cancer Res       Date:  2002-12-15       Impact factor: 12.701

5.  Ultrasonic release of doxorubicin from Pluronic P105 micelles stabilized with an interpenetrating network of N,N-diethylacrylamide.

Authors:  Ghaleb A Husseini; Douglas A Christensen; Natalya Y Rapoport; William G Pitt
Journal:  J Control Release       Date:  2002-10-04       Impact factor: 9.776

6.  Drug delivery in pluronic micelles: effect of high-frequency ultrasound on drug release from micelles and intracellular uptake.

Authors:  Alexandre Marin; Hao Sun; Ghaleb A Husseini; William G Pitt; Douglas A Christensen; Natalya Y Rapoport
Journal:  J Control Release       Date:  2002-11-07       Impact factor: 9.776

7.  Sensitization of cells overexpressing multidrug-resistant proteins by pluronic P85.

Authors:  Elena V Batrakova; Shu Li; Valery Yu Alakhov; William F Elmquist; Donald W Miller; Alexander V Kabanov
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

8.  Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion.

Authors:  E V Batrakova; S Li; W F Elmquist; D W Miller; V Y Alakhov; A V Kabanov
Journal:  Br J Cancer       Date:  2001-12-14       Impact factor: 7.640

9.  Statistics review 12: survival analysis.

Authors:  Viv Bewick; Liz Cheek; Jonathan Ball
Journal:  Crit Care       Date:  2004-09-06       Impact factor: 9.097

10.  Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer.

Authors:  S Danson; D Ferry; V Alakhov; J Margison; D Kerr; D Jowle; M Brampton; G Halbert; M Ranson
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640

View more
  8 in total

Review 1.  Can nanomedicines kill cancer stem cells?

Authors:  Yi Zhao; Daria Y Alakhova; Alexander V Kabanov
Journal:  Adv Drug Deliv Rev       Date:  2013-10-10       Impact factor: 15.470

2.  Role of Pluronic block copolymers in modulation of heat shock protein 70 expression.

Authors:  Reshani H Perera; Tianyi M Krupka; Hanping Wu; Bryan Traughber; David Dremann; Ann-Marie Broome; Agata A Exner
Journal:  Int J Hyperthermia       Date:  2011       Impact factor: 3.914

3.  Formulation and Characterization of Stimuli-Responsive Lecithin-Based Liposome Complexes with Poly(acrylic acid)/Poly(N,N-dimethylaminoethyl methacrylate) and Pluronic® Copolymers for Controlled Drug Delivery.

Authors:  Mónica G Simões; Ayelen Hugo; Andrea Gómez-Zavaglia; Pedro N Simões; Patrícia Alves
Journal:  Pharmaceutics       Date:  2022-03-29       Impact factor: 6.525

4.  Preclinical evaluation of radiosensitizing activity of Pluronic block copolymers.

Authors:  Reshani H Perera; Ravi Patel; Hanping Wu; Mihika Gangolli; Bryan Traughber; Nancy Oleinick; Agata A Exner
Journal:  Int J Radiat Biol       Date:  2013-06-03       Impact factor: 2.694

5.  Nanobubble ultrasound contrast agents for enhanced delivery of thermal sensitizer to tumors undergoing radiofrequency ablation.

Authors:  Reshani H Perera; Luis Solorio; Hanping Wu; Mihika Gangolli; Eric Silverman; Christopher Hernandez; Pubudu M Peiris; Ann-Marie Broome; Agata A Exner
Journal:  Pharm Res       Date:  2013-08-14       Impact factor: 4.200

Review 6.  Pluronics and MDR reversal: an update.

Authors:  Daria Y Alakhova; Alexander V Kabanov
Journal:  Mol Pharm       Date:  2014-07-10       Impact factor: 4.939

Review 7.  Hyperthermia Treatment as a Promising Anti-Cancer Strategy: Therapeutic Targets, Perspective Mechanisms and Synergistic Combinations in Experimental Approaches.

Authors:  Ga Yeong Yi; Min Ju Kim; Hyo In Kim; Jinbong Park; Seung Ho Baek
Journal:  Antioxidants (Basel)       Date:  2022-03-24

8.  Surfactant-assisted individualization and dispersion of boron nitride nanotubes.

Authors:  Ashleigh D Smith McWilliams; Carlos A de Los Reyes; Lucy Liberman; Selin Ergülen; Yeshayahu Talmon; Matteo Pasquali; Angel A Martí
Journal:  Nanoscale Adv       Date:  2018-12-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.